top of page
Sean Hashmi, MD
Admin
More actions
Profile
Join date: Jul 2, 2025
Posts (28)
Mar 13, 2026 ∙ 6 min
SGLT2 vs GLP-1 for Kidney Disease: What the Trial Data Actually Shows
If you have chronic kidney disease, or you love someone who does, you have probably heard about SGLT2 inhibitors and GLP-1 receptor agonists. These two drug classes are reshaping how we protect kidneys, and the clinical trial data behind them is striking. But which one should you ask about first? And what role does something as simple as sleep play in kidney protection? Key Takeaways SGLT2 inhibitors (like dapagliflozin) reduced kidney failure risk by 39% in the DAPA-CKD trial, which was...
5
0
Feb 26, 2026 ∙ 6 min
Should You Quit Coffee? What the Evidence Says
If you've ever wondered whether you should quit coffee, you're not alone. Coffee is one of the most widely consumed beverages in the world, and the research on its health effects can feel contradictory. The truth is that coffee can protect your heart, kidneys, and brain for many people, but for others it does more harm than good. The difference comes down to your genes, your medications, your health conditions, and even your bedtime. Key Takeaways Your CYP1A2 gene determines whether you...
17
0
Feb 22, 2026 ∙ 5 min
Coffee Creamers and Kidney Health: What Additives to Avoid
Are coffee creamers damaging your kidneys? Learn which additives to avoid and how to keep your coffee kidney-friendly. Evidence-based guide.
439
0
1
bottom of page